Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2017

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Gert Richardt

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Mohammed Saad, MD

October 31, 2017

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Todd Neale

October 02, 2017

News Daily News

IABPs Recalled Due to False Blood Detection Alarms and Ingress of Fluid

L.A. McKeown

September 06, 2017

News Daily News

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

Shelley Wood

August 07, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

Recall Underway for Certain IABPs Due to Potential Electrical Test Failure

Todd Neale

June 19, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Daily News

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Todd Neale

April 10, 2017

Presentation TEACH 2016

Management of Shock - What is Happening “under the hood” when Treating Patients with Pressors, IABP, Impella and ECMO

Presenter: Daniel Burkhoff

October 29, 2016

Advertisement

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Acute Cardiogenic Shock: The Case for First-line Use of IABP

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

IABPs Recalled Due to False Blood Detection Alarms and Ingress of Fluid

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

TCTMD’s Top 10 Most Popular Stories for June 2017

Recall Underway for Certain IABPs Due to Potential Electrical Test Failure

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Management of Shock - What is Happening “under the hood” when Treating Patients with Pressors, IABP, Impella and ECMO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content